News Articles

Please view the latest news articles from across Europe below. Alternatively, filter by news category or search by keyword.

ARUP Laboratories To Offer New Blood-Based Colorectal Cancer Screening Test

ARUP Laboratories, a leading national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, announced it is offering the Septin 9 methylated DNA test, a new blood-based colorectal cancer screening method. While ARUP is not the first laboratory to offer this test, this new version, developed and validated independently by ARUP, is clinically proven to detect a higher proportion of colorectal cancers than Septin 9 tests developed by other companies.

"The value of the Septin 9 test to physicians in detecting and treating colorectal cancer cannot be overstated," said Sherrie Perkins, MD, PhD, ARUP's chief medical officer and director of laboratories. "Research has shown that half of the population that should be screened is actually being screened. This blood-based test makes the screening easier and less invasive for patients. The test can be performed on specimens collected in the doctor's office without preparation by the patient, without the time commitment of an endoscopy or the need to handle and mail one's stool as part of a fecal test. Our test is more sensitive than any other on the market; we are able to identify nine out of 10 people with previously undetected colorectal cancer, including those with early stage disease."


For more details View the full story here



The information provided is for interest only and is not a substitute for professional medical advice. You should not rely on this information to make or refrain from making any decisions. Always obtain independent professional advice for your own particular health situation.